Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ranibizumab”

532 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 532 results

Early research (Phase 1)Study completedNCT01968486
What this trial is testing

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Who this might be right for
Myopia, Degenerative
University of Campania Luigi Vanvitelli 60
Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Post-approval studies (Phase 4)Study completedNCT05861466
What this trial is testing

Comparative Study Between IVI of Ranibizumab with and Without Prior ACP in Patients with DME Using OCT-A

Who this might be right for
Diabetic Macular Edema
Ain Shams University 102
Large-scale testing (Phase 3)Study completedNCT00436553
What this trial is testing

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis 321
Not applicableLooking for participantsNCT07520045
What this trial is testing

Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab

Who this might be right for
Diabetic Retinopathy (DR)Diabetic Macular Edema (DME)
Osijek University Hospital 100
Not applicableUnknownNCT04601675
What this trial is testing

Diabetic Macular Edema (DME) Treatment With Ranibizumab and Dexamethasone or Ranibizumab Only.

Who this might be right for
Macular Edema
He Eye Hospital 100
Large-scale testing (Phase 3)Study completedNCT03495765
What this trial is testing

To Evaluate the Comparative Efficacy of Lucentis (Ranibizumab) 0.5mg Intravitreal Injection in Patients With Diabetic Macular Oedema (DME) With Well Controlled and Poorly Controlled Diabetes Mellitus

Who this might be right for
Diabetic Macular Oedema
Marsden Eye Specialists 160
Not applicableStudy completedNCT04377295
What this trial is testing

Evaluation of Retinal and Vascular Features in Radiation Maculopathy After Intravitreal Injections of Ranibizumab

Who this might be right for
Radiation Maculopathy
Federico II University 40
Large-scale testing (Phase 3)Study completedNCT00545870
What this trial is testing

Bevacizumab Versus Ranibizumab for Diabetic Retinopathy

Who this might be right for
Diabetic RetinopathyDiabetic Macular EdemaProliferative Diabetic Retinopathy
Ursula Schmidt-Erfurth, M.D. 30
Testing effectiveness (Phase 2)Study completedNCT00510965
What this trial is testing

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Who this might be right for
Choroidal Neovascularization
University Hospital, Bonn 10
Testing effectiveness (Phase 2)Study completedNCT01445899
What this trial is testing

PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)

Who this might be right for
Choroidal NeovascularizationDiabetic RetinopathyDiabetic Macular Edema
Quark Pharmaceuticals 258
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Not applicableUnknownNCT00994799
What this trial is testing

Comparison of Intravitreal Ranibizumab and Macular Grid-pattern Laser for Treatment of Diabetic Macular Edema

Who this might be right for
Macular Edema
Szeged University 50
Large-scale testing (Phase 3)Study completedNCT02157077
What this trial is testing

Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Macular DegenerationWet Macular DegenerationRetinal Degeneration+2 more
Centre Hospitalier Intercommunal Creteil 90
Early research (Phase 1)Study completedNCT00749021
What this trial is testing

Ranibizumab for Treating Submacular Vascularized Pigment Epithelial Detachments

Who this might be right for
Retinal Pigment Epithelial Detachment
Clement K. Chan 40
Large-scale testing (Phase 3)Study completedNCT02640664
What this trial is testing

Rainbow Extension Study

Who this might be right for
Retinopathy of Prematurity (ROP)
Novartis Pharmaceuticals 180
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Not applicableStudy completedNCT01473251
What this trial is testing

Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration

Who this might be right for
Exudative Macular DegenerationDiabetic Macular Edema
Vitreo-Retinal Associates, Michigan 16
Load More Results